RESEARCHERS IDENTIFY OPTIMAL LENGTH OF PROZAC TREATMENT TO MINIMIZE RELAPSE IN MAJOR DEPRESSION

Update Item Information
Title RESEARCHERS IDENTIFY OPTIMAL LENGTH OF PROZAC TREATMENT TO MINIMIZE RELAPSE IN MAJOR DEPRESSION
Subject Fluoxetine; Antidepressive Agents, Second-Generation; Drug Therapy; Academic Medical Centers; Hospitals, University; Public Relations; Communications Media; Mass Media; Social Marketing; Information Dissemination; News; Press Release; Prozac
Description SALT LAKE CITY, September 1,1998 - Depressed patients treated with Prozac (fluoxetine hydrochloride) for 38 weeks showed significantly lower relapse rates than those who discontinued therapy earlier, according to a study published today in the American Icumal of Psychiatry.
Publisher University of Utah Health Care Office of Public Affairs and Marketing
Date 1998-09-01
Language eng
Relation University of Utah Health Care Office of Public Affairs and Marketing Collection
Rights Management Copyright 2012
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Scanning Technician sg
Relation is Part of Press Releases; University of Utah Health Sciences Center News
Type Text
ARK ark:/87278/s6rz26ww
Setname ehsl_pahsc
ID 935226
Reference URL https://collections.lib.utah.edu/ark:/87278/s6rz26ww
Back to Search Results